HIV-associated neuropathogenesis: A systems biology perspective for modeling and therapy

Despite the development of powerful antiretroviral drugs, HIV-1 associated neurological disorders (HAND) will affect approximately half of those infected with HIV-1. Combined anti-retroviral therapy (cART) targets viral replication and increases T-cell counts, but it does not always control macrophage polarization, brain infection or inflammation. Moreover, it remains difficult to identify those at risk for HAND. New therapies that focus on modulating host immune response by making use of biological pathways could prove to be more effective than cART for the treatment of neuroAIDS. Additionally, while numerous HAND biomarkers have been suggested, they are of little use without methods for appropriate data integration and a systems-level interpretation. Machine learning, could be used to develop multifactorial computational models that provide clinicians and researchers with the ability to identify which factors (in what combination and relative importance) are considered important to outcome.

[1]  A. Basu,et al.  Microglial response to viral challenges: every silver lining comes with a cloud. , 2011, Frontiers in bioscience.

[2]  R. Steinman,et al.  The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus Δnef , 2007 .

[3]  Takashi Fukaya,et al.  PABP is not essential for microRNA‐mediated translational repression and deadenylation in vitro , 2011, The EMBO journal.

[4]  Robert M. Stephens,et al.  Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties. , 2013, Biochemical and biophysical research communications.

[5]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[6]  H. Xiong,et al.  Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia. , 1999, Journal of neurovirology.

[7]  Y. Mizuguchi,et al.  RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS , 2007, Brain Research.

[8]  M. McGrath,et al.  HIV-1 Nef Protein Structures Associated with Brain Infection and Dementia Pathogenesis , 2011, PloS one.

[9]  Rebecca R. Gray,et al.  Distinct Patterns of HIV-1 Evolution within Metastatic Tissues in Patients with Non-Hodgkins Lymphoma , 2009, PloS one.

[10]  H. Gendelman Biomarkers, Laboratory, and Animal Models for the Design and Development of Adjunctive Therapies for HIV-1 Dementia and other Neuroinflammatory Disorders , 2007, Journal of Neuroimmune Pharmacology.

[11]  W. Fitch,et al.  Phylodynamic Analysis of Human Immunodeficiency Virus Type 1 in Distinct Brain Compartments Provides a Model for the Neuropathogenesis of AIDS , 2005, Journal of Virology.

[12]  Guoku Hu,et al.  MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection. , 2010, The Journal of infectious diseases.

[13]  R. Price,et al.  Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection , 1990, Annals of neurology.

[14]  C. Cordon-Cardo,et al.  HIV antigen in the brains of patients with the AIDS dementia complex , 1987, Annals of neurology.

[15]  H. Fox,et al.  MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease , 2010, Cell Death and Disease.

[16]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[17]  M. Tyrer,et al.  HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape , 2011, International journal of STD & AIDS.

[18]  S. Croul,et al.  CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection , 2011, Journal of NeuroVirology.

[19]  P. Lantos,et al.  HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology , 1991, Brain pathology.

[20]  M. Al-Omran,et al.  Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. , 2010, American journal of physiology. Heart and circulatory physiology.

[21]  A. Puig-Kröger,et al.  Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. , 2011, Blood.

[22]  Xavier Alvarez,et al.  Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system , 2001, Glia.

[23]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[24]  H. Pfister,et al.  HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. , 1999, Journal of immunology.

[25]  E. Robertson,et al.  Upregulation of Cellular Bcl-2 by the KSHV Encoded RTA Promotes Virion Production , 2011, PloS one.

[26]  P. Kleihues,et al.  PCR identification of HIV‐1 DNA sequences in brain tissue of patients with AIDS encephalopathy , 1993, Neurology.

[27]  Honghong Yao,et al.  HIV Neuropathogenesis: a Tight Rope Walk of Innate Immunity , 2010, Journal of Neuroimmune Pharmacology.

[28]  F. Pixley,et al.  CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways , 2012, Critical reviews in clinical laboratory sciences.

[29]  K. Williams,et al.  Monocyte Mobilization, Activation Markers, and Unique Macrophage Populations in the Brain: Observations from SIV Infected Monkeys Are Informative with Regard to Pathogenic Mechanisms of HIV Infection in Humans , 2011, Journal of Neuroimmune Pharmacology.

[30]  J. Clements,et al.  Expression of Simian Immunodeficiency Virus (SIV) Nef in Astrocytes during Acute and Terminal Infection and Requirement of Nef for Optimal Replication of Neurovirulent SIV In Vitro , 2003, Journal of Virology.

[31]  G. Hannon,et al.  A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.

[32]  L. Rajendran,et al.  Retromers in Alzheimer’s Disease , 2012, Neurodegenerative Diseases.

[33]  R. Jack,et al.  Origin of monocytes and their differentiation to macrophages and dendritic cells. , 2006, Journal of endotoxin research.

[34]  K. Marder,et al.  Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. , 2004, Archives of neurology.

[35]  P. Allavena,et al.  Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. , 2009, Human immunology.

[36]  Erick R. Scott,et al.  Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-Infected Brain: Novel Analysis of Retrospective Cases , 2010, PloS one.

[37]  G. Poli,et al.  Macrophage polarization and HIV‐1 infection , 2010, Journal of leukocyte biology.

[38]  H. Fox,et al.  Quantitative Proteomics by SWATH-MS Reveals Altered Expression of Nucleic Acid Binding and Regulatory Proteins in HIV-1-Infected Macrophages , 2014, Journal of proteome research.

[39]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[40]  D. Walsh,et al.  Viral subversion of the host protein synthesis machinery , 2011, Nature Reviews Microbiology.

[41]  Kristian Helin,et al.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. , 2006, Genes & development.

[42]  M. Gill,et al.  Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. , 2004, Virology.

[43]  T. Langford,et al.  Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir , 2008, BMC Neuroscience.

[44]  R. Jack,et al.  Invited review: Origin of monocytes and their differentiation to macrophages and dendritic cells , 2006 .

[45]  W. Snider,et al.  Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients , 1983, Annals of neurology.

[46]  C. Sabin,et al.  Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy , 2008, Annals of neurology.

[47]  C. Salata,et al.  Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia , 2009, Journal of NeuroVirology.

[48]  Viraj R Sanghvi,et al.  The Cellular TAR RNA Binding Protein, TRBP, Promotes HIV-1 Replication Primarily by Inhibiting the Activation of Double-Stranded RNA-Dependent Kinase PKR , 2011, Journal of Virology.

[49]  B. Verdoodt,et al.  MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B , 2011, Laboratory Investigation.

[50]  W. Wachsman,et al.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection , 1992, Neurology.

[51]  Rebecca R. Gray,et al.  Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain , 2010, Journal of NeuroVirology.

[52]  G. Fogel,et al.  Extensive HIV-1 Intra-Host Recombination Is Common in Tissues with Abnormal Histopathology , 2009, PloS one.

[53]  F. Kashanchi,et al.  Loss of G1/S Checkpoint in Human Immunodeficiency Virus Type 1-Infected Cells Is Associated with a Lack of Cyclin-Dependent Kinase Inhibitor p21/Waf1 , 2000, Journal of Virology.

[54]  F. Pereyra,et al.  Differential microRNA regulation of HLA-C expression and its association with HIV control , 2011, Nature.

[55]  M. Falchi,et al.  Macrophages Transmit Human Immunodeficiency Virus Type 1 Products to CD4-Negative Cells: Involvement of Matrix Metalloproteinase 9 , 2007, Journal of Virology.

[56]  S. Devaraj,et al.  C-Reactive Protein Polarizes Human Macrophages to an M1 Phenotype and Inhibits Transformation to the M2 Phenotype , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[57]  K. Jeang,et al.  MicroRNAs and human retroviruses , 2011, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.

[58]  S. Burakoff,et al.  Lysine 144, a Ubiquitin Attachment Site in HIV-1 Nef, Is Required for Nef-Mediated CD4 Down-Regulation1 , 2008, The Journal of Immunology.

[59]  G. Pavlakis,et al.  Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function , 1995, Journal of virology.

[60]  H. Budka,et al.  Brain pathology induced by infection with the human immunodeficiency virus (HIV) , 1987, Acta Neuropathologica.

[61]  Liangbiao Chen,et al.  Multi-class cancer classification through gene expression profiles: microRNA versus mRNA. , 2009, Journal of genetics and genomics = Yi chuan xue bao.

[62]  Jessica M. Winkler,et al.  The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment , 2012, PloS one.

[63]  E. Ponomarev,et al.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity , 2005, Journal of neuroscience research.

[64]  M. Salemi,et al.  High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS , 2009, Science in China Series C: Life Sciences.

[65]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[66]  H. Budka The Definition of HIV‐specific Neuropathology , 1991, Acta pathologica japonica.

[67]  Julie A Saugstad,et al.  MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and Neurodegeneration , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[68]  M. Bouhlel,et al.  Peroxisome proliferator‐activated receptors – from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease , 2007, Journal of internal medicine.

[69]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[70]  G. Fogel,et al.  HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis? , 2010, Current HIV research.

[71]  David Pinson,et al.  CXCL10‐induced cell death in neurons: role of calcium dysregulation , 2006, The European journal of neuroscience.

[72]  B. Brüne,et al.  Redox control of inflammation in macrophages. , 2013, Antioxidants & redox signaling.

[73]  H. Gendelman,et al.  Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: A therapeutic strategy based on modulation of mixed lineage kinase , 2010, Neurotherapeutics.

[74]  Aadel A. Chaudhuri,et al.  Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder , 2008, The Journal of experimental medicine.

[75]  Marianne K Henderson,et al.  Biospecimens and Biorepositories: From Afterthought to Science , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[76]  J. Clements,et al.  Eradication of HIV from the brain: reasons for pause. , 2011, AIDS.

[77]  B. Navia,et al.  The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.

[78]  A. Lackner,et al.  Monocyte/macrophages and their role in HIV neuropathogenesis , 2013, Immunological reviews.

[79]  E. Eklund,et al.  HoxA10 Activates CDX4 Transcription and Cdx4 Activates HOXA10 Transcription in Myeloid Cells* , 2011, The Journal of Biological Chemistry.

[80]  M. Altfeld,et al.  Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells1 , 2007, The Journal of Immunology.

[81]  F. Pixley Macrophage Migration and Its Regulation by CSF-1 , 2012, International journal of cell biology.

[82]  G. Fogel,et al.  HIV-1 Nef in Macrophage-Mediated Disease Pathogenesis , 2012, International reviews of immunology.

[83]  D. Richman,et al.  Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. , 1987, Annals of internal medicine.

[84]  O. Lunov,et al.  Thioredoxin-1 Promotes Anti-Inflammatory Macrophages of the M2 Phenotype and Antagonizes Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[85]  P. Annunziata Blood-brain barrier changes during invasion of the central nervous system by HIV-1 , 2003, Journal of Neurology.

[86]  Jianhui Zhong,et al.  Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment , 2011, AIDS.

[87]  H. Uno,et al.  Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection , 2012, Journal of acquired immune deficiency syndromes.

[88]  E. Junn,et al.  MicroRNAs in neurodegenerative diseases and their therapeutic potential. , 2012, Pharmacology & therapeutics.

[89]  Nectarios Koziris,et al.  TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support , 2011, Nucleic Acids Res..

[90]  Bard Ermentrout,et al.  Translational Systems Approaches to the Biology of Inflammation and Healing , 2010, Immunopharmacology and immunotoxicology.

[91]  E. Masliah,et al.  Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders , 1997, Annals of neurology.

[92]  H. Weiner,et al.  MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS , 2013, Glia.

[93]  B. Brew,et al.  Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat , 2011, Journal of NeuroVirology.

[94]  I. Mocchetti,et al.  When Human Immunodeficiency Virus Meets Chemokines and Microglia: Neuroprotection or Neurodegeneration? , 2012, Journal of Neuroimmune Pharmacology.

[95]  R. Price,et al.  The AIDS dementia complex. , 1988, The Journal of infectious diseases.

[96]  J. Clements,et al.  Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood–Brain Barrier Integrity by a Gap Junction-Dependent Mechanism , 2011, The Journal of Neuroscience.

[97]  Dianwen Zhu,et al.  CUNY Academic , 2016 .

[98]  W. Sui,et al.  Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. , 2008, Transplant immunology.

[99]  A. Bergamini,et al.  Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. , 1999, The Journal of infectious diseases.

[100]  Bell Je The neuropathology of adult HIV infection. , 1998 .

[101]  M. Mostarica Stojković,et al.  CXCL12: role in neuroinflammation. , 2012, The international journal of biochemistry & cell biology.

[102]  P. Allavena,et al.  Macrophage polarization in tumour progression. , 2008, Seminars in cancer biology.

[103]  J. Pollack,et al.  MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. , 2008, Blood.

[104]  Ping Wang,et al.  Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization , 1998, Journal of cellular biochemistry.

[105]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[106]  Helen M. Moore,et al.  An NCI perspective on creating sustainable biospecimen resources. , 2011, Journal of the National Cancer Institute. Monographs.

[107]  G. Fogel,et al.  Prediction of R5, X4, and R5X4 HIV-1 Coreceptor Usage with Evolved Neural Networks , 2008, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[108]  C. Münz Beclin-1 Targeting for Viral Immune Escape , 2011, Viruses.

[109]  B. Berkhout,et al.  RISCy Business: MicroRNAs, Pathogenesis, and Viruses* , 2007, Journal of Biological Chemistry.

[110]  G. Garden Microglia in human immunodeficiency virus‐associated neurodegeneration , 2002, Glia.

[111]  A. Varin,et al.  The macrophage in HIV-1 infection: From activation to deactivation? , 2010, Retrovirology.

[112]  L. Ayers,et al.  The AIDS and Cancer Specimen Resource: Role in HIV/AIDS scientific discovery , 2007, Infectious Agents and Cancer.

[113]  S. Kramer,et al.  HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner , 2006, Journal of Cell Science.

[114]  P. Shapshak,et al.  Regulation of HIV-1 infection in astrocytes: expression of Nef, TNF-alpha and IL-6 is enhanced in coculture of astrocytes with macrophages. , 1996, Journal of neurovirology.

[115]  Hideaki Ando,et al.  An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP , 2008, Proceedings of the National Academy of Sciences.

[116]  E. Masliah,et al.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis , 2002, Neurology.

[117]  Johnny J. He,et al.  HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs* , 2011, The Journal of Biological Chemistry.

[118]  K. Williams,et al.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. , 2002, Annual review of neuroscience.

[119]  D. Moore,et al.  Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy , 2009, Journal of NeuroVirology.

[120]  Wei Chen,et al.  The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. , 2012, Toxicology letters.

[121]  I. Grant,et al.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. , 2008, Archives of neurology.